Standout Papers

A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cys... 2014 2026 2018 2022 328
  1. A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial (2014)
    Michael Boyle, Scott C. Bell et al. The Lancet Respiratory Medicine

Immediate Impact

18 by Nobel laureates 14 from Science/Nature 80 standout
Sub-graph 1 of 19

Citing Papers

Cystic Fibrosis
2023 Standout
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
25 intermediate papers

Works of David M. Rodman being referenced

Repeated Adeno-Associated Virus Serotype 2 Aerosol-Mediated Cystic Fibrosis Transmembrane Regulator Gene Transfer to the Lungs of Patients With Cystic Fibrosis
2004
Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi‐center study
2001
and 5 more

Author Peers

Author Last Decade Papers Cites
David M. Rodman 3203 2049 1564 98 5.5k
N. F. Voelkel 3030 1255 1277 86 5.4k
Troy Stevens 1762 1383 3136 151 6.5k
Frank Rose 2826 858 1545 68 5.0k
Richard Robbins 2853 2710 906 153 7.0k
J. Usha Raj 3037 1004 1722 179 5.2k
Victor E. Laubach 1483 2064 1888 142 7.6k
Ludger Fink 2495 817 2579 113 6.4k
G Bonsignore 2423 3102 788 121 5.2k
Jay Y. Westcott 1705 2093 1369 83 6.2k
Takayuki Kuriyama 2166 1342 887 175 4.8k

All Works

Loading papers...

Rankless by CCL
2026